Evidence map›Paper›PMID 42482444›Full record

ArticleAdvanced healthcare materials2026

Development of a Novel Fluorescent Recognition Guidewire System Toward Early Lung Cancer Biopsy.

Jiatian Chen, Lei Li, Xianbing Zeng, Qianhui Wang, Shengchang Zhang, Juncai Song, Yujing Li, Guanghao Wu, Yue Yin, Yubing Guo

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiatian ChenSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Lei LiSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Xianbing ZengSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Qianhui WangSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Shengchang ZhangSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Juncai SongSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Yujing LiSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.ORCID https://orcid.org/0000-0001-6643-7676
Guanghao WuSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.
Yue YinCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
Yubing GuoSchool of Medical Science and Engineering, Beijing Institute of Technology, Beijing, China.ORCID https://orcid.org/0000-0002-6800-8899

Funding

Beijing Natural Science Foundation 7252290National Natural Science Foundation of China 52375560
6 · The paper itself

Abstract

Obtaining tissue biopsies from peripheral pulmonary lesions remains challenging due to the limited maneuverability of conventional bronchoscopic instruments in distal airways and the inability to distinguish malignant from benign tissue in real time. Here, we present a proof-of-concept guidewire-based biopsy system that integrates magnetic actuation for flexible navigation with fluorescence imaging for targeted lesion identification. The system comprises a magnetically driven biopsy tool, a miniaturized camera with an optical filter, a 488 nm laser fiber for fluorescence excitation, and a white-light illumination fiber. Under external magnetic field control (10-40 mT), the system achieved a maximum deflection angle of 32.60° ± 1.03° (90° magnetic field) and successfully navigated through a scaled bronchial phantom to reach multiple target branches. Using FITC-conjugated anti-EGFR antibody-labeled A549 cell spheroids as simulated tumor targets, the system demonstrated real-time fluorescence identification and targeted biopsy, recovering 23.40% ± 2.63% of spheroid cells per sampling session. Navigation and biopsy capabilities were further validated in ex vivo porcine lungs. This integrated approach addresses both the navigation and target identification challenges inherent in peripheral lung biopsy and provides a foundation for future development toward clinical application.

Indexed as

Lung NeoplasmsOptical ImagingA549 CellsAnimalsBiopsyHumansPhantoms, ImagingSpheroids, CellularSwinecell spheroidsfluorescence imagingguidewirelung cancertissue biopsy

Identifiers

PMID42482444
PMCPMC13507624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.